Ctrl Worx Watch List › Company
Glucotrack, Inc. (GCTK): material weakness open 1,763 days
By Russell Tomoum, Ctrl Worx™. Built from its own SEC filings. How the Clock works.
Glucotrack, Inc. reported ineffective internal control over financial reporting because of a material weakness in 5 filings since Mar 31, 2022. It stated one or more material weaknesses in 14 more SEC filings that gave no conclusion on whether that control is effective. The latest was its 10-Q for the period ended Jun 30, 2026.
Ctrl Worx Watch List™ status
On the ClockStill filing, and no annual report of its own says the weakness is fixed.
Checked against SEC EDGAR: Oct 29, 2026 · Entry #10870
Causes the company named
Segregation of duties · 15Accounting expertise and resources · 15ITGC: general · 15Complex or non-routine accounting · 8Entity-level and governance · 8Not described · 4
Insufficient IT controls, accounting personnel, and segregation of duties in financial reporting.
What the latest filing says
ation required to be included in periodic filings under the Exchange Act and that such information is not accumulated and communicated to management, including our principal executive officer, in a manner sufficient to allow timely decisions regarding required disclosure. The Company has identified material weaknesses in its internal control over financial reporting. As defined in Regulation 12b-2 under the Exchange Act, a “material weakness” is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented, or detected on a timely basis. The Company identified material weaknesses in its internal controls in the following areas: general IT controls; lack of sufficient accounting personnel and inadequate segregation of duties consistent with control objectives. None of these deficiencies resulted in a material misstatement to the Company’s interim and annual Consolidated Financial Statements for the periods ende [...]
From the controls section of the 10-Q filed Aug 14, 2026. Read the full filing on SEC EDGAR.
Company response: Glucotrack, Inc. can send a statement or a link to its remediation update to russell@ctrlworx.com. We post it here, unedited and dated.
Filings
| Filed | Form | Period | Controls | Causes | Filing |
|---|---|---|---|---|---|
| Aug 14, 2026 | 10-Q | Jun 30, 2026 | Material weakness stated, no ICFR conclusion | Segregation of duties; Accounting expertise and resources; ITGC: general | EDGAR |
| May 14, 2026 | 10-Q | Mar 31, 2026 | Material weakness stated, no ICFR conclusion | Segregation of duties; Accounting expertise and resources; ITGC: general | EDGAR |
| Mar 30, 2026 | 10-K | Dec 31, 2025 | Not effective | Segregation of duties; Accounting expertise and resources; ITGC: general | EDGAR |
| Nov 13, 2025 | 10-Q | Sep 30, 2025 | Material weakness stated, no ICFR conclusion | Segregation of duties; Accounting expertise and resources; ITGC: general | EDGAR |
| Aug 14, 2025 | 10-Q | Jun 30, 2025 | Material weakness stated, no ICFR conclusion | Segregation of duties; Accounting expertise and resources; ITGC: general | EDGAR |
| May 14, 2025 | 10-Q | Mar 31, 2025 | Material weakness stated, no ICFR conclusion | Segregation of duties; Accounting expertise and resources; ITGC: general | EDGAR |
| Mar 31, 2025 | 10-K | Dec 31, 2024 | Not effective | Segregation of duties; Accounting expertise and resources; ITGC: general | EDGAR |
| Nov 14, 2024 | 10-Q | Sep 30, 2024 | Material weakness stated, no ICFR conclusion | Segregation of duties; Accounting expertise and resources; Complex or non-routine accounting; ITGC: general; Entity-level and governance | EDGAR |
| Aug 13, 2024 | 10-Q | Jun 30, 2024 | Material weakness stated, no ICFR conclusion | Segregation of duties; Accounting expertise and resources; Complex or non-routine accounting; ITGC: general; Entity-level and governance | EDGAR |
| May 15, 2024 | 10-Q | Mar 31, 2024 | Material weakness stated, no ICFR conclusion | Segregation of duties; Accounting expertise and resources; Complex or non-routine accounting; ITGC: general; Entity-level and governance | EDGAR |
| Mar 28, 2024 | 10-K | Dec 31, 2023 | Not effective | Segregation of duties; Accounting expertise and resources; Complex or non-routine accounting; ITGC: general; Entity-level and governance | EDGAR |
| Nov 14, 2023 | 10-Q | Sep 30, 2023 | Material weakness stated, no ICFR conclusion | Segregation of duties; Accounting expertise and resources; Complex or non-routine accounting; ITGC: general; Entity-level and governance | EDGAR |
| Aug 14, 2023 | 10-Q | Jun 30, 2023 | Material weakness stated, no ICFR conclusion | Segregation of duties; Accounting expertise and resources; Complex or non-routine accounting; ITGC: general; Entity-level and governance | EDGAR |
| May 12, 2023 | 10-Q | Mar 31, 2023 | Material weakness stated, no ICFR conclusion | Not described | EDGAR |
| Mar 31, 2023 | 10-K | Dec 31, 2022 | Not effective | Segregation of duties; Accounting expertise and resources; Complex or non-routine accounting; ITGC: general; Entity-level and governance | EDGAR |
| Nov 14, 2022 | 10-Q | Sep 30, 2022 | Material weakness stated, no ICFR conclusion | Not described | EDGAR |
| Aug 15, 2022 | 10-Q | Jun 30, 2022 | Material weakness stated, no ICFR conclusion | Not described | EDGAR |
| May 16, 2022 | 10-Q | Mar 31, 2022 | Material weakness stated, no ICFR conclusion | Not described | EDGAR |
| Mar 31, 2022 | 10-K | Dec 31, 2021 | Not effective | Segregation of duties; Accounting expertise and resources; Complex or non-routine accounting; ITGC: general; Entity-level and governance | EDGAR |
Others on the Clock in the same industry
By SEC industry code: 3841, Surgical & Medical Instruments & Apparatus, then related codes.
- DIH HOLDING US, INC. (DHAI) · open since Mar 2022
- Tenon Medical, Inc. (TNON) · open since Mar 2022
- Nuo Therapeutics, Inc. (AURX) · open since Sep 2021
- RetinalGenix Technologies Inc. (RTGN) · open since Sep 2021
- VYCOR MEDICAL INC (VYCO) · open since Jun 2021
Follow GCTK for free
Get an email when Glucotrack, Inc files a 10-K or 10-Q that reports a material weakness, or says its controls are effective again.
Want the next one the day it's filed?
MW Pro sends an alert the day a company you follow reports a material weakness or says it fixed one. Founding price $990 a year.
Join the MW Pro waitlistLook up any company in Controls Radar™Based on public SEC filings. Causes are grouped into standard categories by Ctrl Worx. The filings are the authority. Ctrl Worx is not affiliated with Glucotrack, Inc. or the SEC. Not investment advice. Why you can rely on the Watch List.